NASDAQ:YTEN Yield10 Bioscience (YTEN) Stock Price, News & Analysis $0.02 0.00 (0.00%) As of 06/9/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsInsider TradesSEC FilingsTrendsBuy This Stock About Yield10 Bioscience Stock (NASDAQ:YTEN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Yield10 Bioscience alerts:Sign Up Key Stats Today's Range$0.0150▼$0.015050-Day Range$0.0150▼$0.015052-Week Range$0.31▼$17.26VolumeN/AAverage Volume78,164 shsMarket Capitalization$11.01 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewYield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, renewable diesel (RD), and sustainable aviation fuel (SAF). The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts.Read More… Receive YTEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address YTEN Stock News HeadlinesYield10 Bioscience Files for Chapter 11 BankruptcyDecember 6, 2024 | tipranks.comYield10 Bioscience (OTC:YTEN) Stock, Insider Trading ActivityOctober 6, 2024 | benzinga.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.June 11, 2025 | Porter & Company (Ad)Yield10 Bioscience (OTC:YTEN) Stock Quotes, Forecast and News SummaryOctober 6, 2024 | benzinga.comYield10 Bioscience, Inc.: Yield10 Bioscience Announces Second Quarter 2024 Financial ResultsAugust 15, 2024 | finanznachrichten.deYield10 Bioscience Announces Second Quarter 2024 Financial ResultsAugust 14, 2024 | globenewswire.comYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 17, 2024 | globenewswire.comYield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of AssetsJuly 17, 2024 | globenewswire.comSee More Headlines YTEN Stock Analysis - Frequently Asked Questions How have YTEN shares performed this year? Yield10 Bioscience's stock was trading at $0.3120 on January 1st, 2025. Since then, YTEN shares have decreased by 95.2% and is now trading at $0.0150. View the best growth stocks for 2025 here. How were Yield10 Bioscience's earnings last quarter? Yield10 Bioscience, Inc. (NASDAQ:YTEN) released its earnings results on Tuesday, November, 9th. The specialty chemicals company reported ($11.76) EPS for the quarter, topping analysts' consensus estimates of ($15.60) by $3.84. The specialty chemicals company had revenue of $0.09 million for the quarter, compared to the consensus estimate of $0.22 million. When did Yield10 Bioscience's stock split? Yield10 Bioscience shares reverse split before market open on Friday, May 3rd 2024. The 1-24 reverse split was announced on Friday, May 3rd 2024. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 3rd 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Yield10 Bioscience? Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Yield10 Bioscience own? Based on aggregate information from My MarketBeat watchlists, some other companies that Yield10 Bioscience investors own include Canopy Growth (CGC), KushCo (KSHB), NVIDIA (NVDA), Advanced Micro Devices (AMD), OPKO Health (OPK), Pfizer (PFE) and FuelCell Energy (FCEL). Company Calendar Last Earnings11/09/2021Today6/10/2025Next Earnings (Estimated)8/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Agricultural production - crops Sub-IndustryAgriculture Current SymbolNASDAQ:YTEN CIK1121702 Webwww.yield10bio.com Phone(617) 583-1700Fax617-583-1768Employees30Year Founded1992Profitability EPS (Most Recent Fiscal Year)($26.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.45 million Net MarginsN/A Pretax Margin-1,693.60% Return on EquityN/A Return on Assets-296.08% Debt Debt-to-Equity RatioN/A Current Ratio0.16 Quick Ratio0.16 Sales & Book Value Annual Sales$60 thousand Price / Sales0.18 Cash FlowN/A Price / Cash FlowN/A Book Value($4.97) per share Price / Book0.00Miscellaneous Outstanding Shares734,000Free Float689,000Market Cap$11.01 thousand OptionableNot Optionable Beta1.48 Social Links 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NASDAQ:YTEN) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Yield10 Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Yield10 Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.